Till Eichenauer

437 total citations
13 papers, 211 citations indexed

About

Till Eichenauer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Till Eichenauer has authored 13 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Till Eichenauer's work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (6 papers) and Prostate Cancer Treatment and Research (5 papers). Till Eichenauer is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Renal and related cancers (6 papers) and Prostate Cancer Treatment and Research (5 papers). Till Eichenauer collaborates with scholars based in Germany and Sweden. Till Eichenauer's co-authors include Guido Sauter, Ronald Simon, Michael Rink, Waldemar Wilczak, Margit Fisch, Franziska Büscheck, Christoph Fraune, Stefan Steurer, Markus Graefen and Sarah Minner and has published in prestigious journals such as The Journal of Urology, The Journal of Pathology and Human Pathology.

In The Last Decade

Till Eichenauer

13 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Till Eichenauer Germany	8	125	123	64	55	22	13	211
Lori Kollath United States	5	126 1.0×	140 1.1×	60 0.9×	76 1.4×	24 1.1×	7	234
Shuqiong Fan China	7	102 0.8×	91 0.7×	57 0.9×	88 1.6×	20 0.9×	10	204
Kenneth Wha Eng United States	3	129 1.0×	72 0.6×	80 1.3×	39 0.7×	15 0.7×	4	187
Marta Román Spain	5	168 1.3×	126 1.0×	68 1.1×	116 2.1×	12 0.5×	7	306
Phuong Vu Norway	7	107 0.9×	64 0.5×	106 1.7×	139 2.5×	24 1.1×	12	258
S. Gadgeel United States	5	133 1.1×	153 1.2×	67 1.0×	129 2.3×	8 0.4×	16	262
Guangzheng Deng China	7	129 1.0×	61 0.5×	106 1.7×	135 2.5×	30 1.4×	9	282
Zixin Guo China	9	111 0.9×	129 1.0×	99 1.5×	59 1.1×	11 0.5×	19	220
Rongzhen Luo China	8	102 0.8×	44 0.4×	95 1.5×	70 1.3×	14 0.6×	11	218
LeAnn Oseth United States	7	119 1.0×	158 1.3×	65 1.0×	36 0.7×	17 0.8×	7	269

Countries citing papers authored by Till Eichenauer

Since Specialization

Citations

This map shows the geographic impact of Till Eichenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Eichenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Eichenauer more than expected).

Fields of papers citing papers by Till Eichenauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Eichenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Eichenauer. The network helps show where Till Eichenauer may publish in the future.

Co-authorship network of co-authors of Till Eichenauer

This figure shows the co-authorship network connecting the top 25 collaborators of Till Eichenauer. A scholar is included among the top collaborators of Till Eichenauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Eichenauer. Till Eichenauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lennartz, Maximilian, Christian Bernreuther, Franziska Büscheck, et al.. (2022). Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16. Urologic Oncology Seminars and Original Investigations. 40(7). 348.e1–348.e8. 1 indexed citations

Marx, Andreas H., Doris Höflmayer, Franziska Büscheck, et al.. (2021). Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. Cancer Biology and Medicine. 18(1). 245–255. 16 indexed citations

Büscheck, Franziska, Christoph Fraune, Ronald Simon, et al.. (2021). Y-chromosome loss is frequent in male renal tumors. Annals of Translational Medicine. 9(3). 209–209. 23 indexed citations

Eichenauer, Till, Martina Kluth, Cosima Göbel, et al.. (2020). Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma. World Journal of Surgical Oncology. 18(1). 128–128. 2 indexed citations

Büscheck, Franziska, Christoph Fraune, Martina Kluth, et al.. (2020). A non-diploid DNA status is linked to poor prognosis in renal cell cancer. World Journal of Urology. 39(3). 829–837. 1 indexed citations

Eichenauer, Till, Christoph Fraune, Tim Mandelkow, et al.. (2020). High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. World Journal of Urology. 39(2). 481–490. 10 indexed citations

Büscheck, Franziska, Christoph Fraune, Ronald Simon, et al.. (2020). Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes. Oncotarget. 11(3). 237–249. 19 indexed citations

Büscheck, Franziska, Christoph Fraune, Ronald Simon, et al.. (2018). Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(12). 531.e19–531.e25. 19 indexed citations

Hinsch, Andrea, Christina Koop, Maria Christina Tsourlakis, et al.. (2016). β III-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer. Human Pathology. 61. 210–220. 21 indexed citations

10.

Ohlsson, Mattias, Reza Kaboteh, Aseem Anand, et al.. (2016). Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice. European Urology Focus. 2(5). 540–546. 24 indexed citations

11.

Eichenauer, Till, Thomas Steuber, Georg Salomon, et al.. (2014). 722 Size and extension of lymph node metastases in prostate cancer patients: Implications for radiological imaging based on 6804 lymph nodes. European Urology Supplements. 13(1). e722–e722. 2 indexed citations

12.

Meyer, Christian, Till Eichenauer, Thomas Steuber, et al.. (2014). PD15-10 SIZE AND EXTENSION OF LYMPH NODE METASTASES IN PROSTATE CANCER PATIENTS: IMPLICATIONS FOR RADIOLOGICAL IMAGING BASED ON 6804 LYMPH NODES. The Journal of Urology. 191(4S). 2 indexed citations

13.

Krohn, Antje, Lia Burkhardt, Malte Mäder, et al.. (2013). Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers. The Journal of Pathology. 231(1). 130–141. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact